Expression of an acidic lysosomal protease, cathepsin-D (CD), was anal
ysed immunohistochemically in a series of 151 breast carcinomas with s
pecial reference to its prognostic significance, Strong expression of
CD was detected in 22% of cases. This intense expression was significa
ntly associated with a number of established prognostic factors, inclu
ding the non-ductal type of carcinoma (p=0.0243) and metastases at the
time of diagnosis (p=0.0068). On the other hand, high expression of C
D was not related to the lymph-node status, tumour size, ER/PR content
or histological grade. Patients with CD overexpression has a signific
antly lower survival probability (p=0.0478) than did the patients with
low expression of this protease. The relationship between the high ex
pression of CD and shelf disease-free survival was almost significant
(p=0.0519). Intense immunostaining of CD was associated with a signifi
cantly impaired disease outlook in patients with confirmed lymph node
metastasis (N+) (p=0.0137) but not in those with negative lymph nodes
(N-) (p=0.0620). In Cox's multivariate analysis, expression of CD had
no independent prognostic value over the conventional prognostic facto
rs. The results suggest that expression of CD is of borderline signifi
cance in evaluating the intrinsic malignancy of female breast cancer i
n general. The potential of CD as a prognostic factor in specific subg
roups of breast cancers will be the subject of further studies.